×

Message

EU e-Privacy Directive

This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.

View e-Privacy Directive Documents

You have declined cookies. This decision can be reversed.

Dietary Modification - Elemental Diet

Intestinal permeability in Crohn's disease and effects of elemental dietary therapy

Written by CYBERMED LIFE NEWS
Abstract Title:

[Intestinal permeability in Crohn's disease and effects of elemental dietary therapy].

Abstract Source:

Nippon Shokakibyo Gakkai Zasshi. 2001 Jun;98(6):636-43. PMID: 11436280

Abstract Author(s):

M Iwata, H Nakano, Y Matsuura, M Nagasaka, M Misawa, S Mizuta, I Ito, T Saito, T Ito, M Hokama, M Kamiya, R Hobara, M Watanabe, K Takahama

Article Affiliation:

Department of Internal Medicine and Gastroenterology, Fujita Health University.

Abstract:

Enteral intake of non-metabolic monosacharide and disaccharide, followed by measurement of the urinary excretion ratio of the two, is a method used to investigate intestinal permeability. L/R ratio (lactulose/1-rhamnose urinary excretion ratio) is considered an indicator of permeability of the small intestine. An increased L/R ratio is caused by mucosal disorders of the small intestine. The L/R ratio in all patients (n = 92) with Crohn's disease was 0.079 +/- 0.081 (mean +/- S.D.), which was significantly higher than the value in normal controls (0.027 +/- 0.009, n = 20, p<0.05). In 39 patients with Crohn's disease, we assessed intestinal permeability before after treatment with an elemental diet, and during remission. The L/R ratio was 0.120 +/- 0.092, before treatment and 0.065 +/- 0.097 after treatment (p<0.05), showing increased intestinal permeability before elemental dietary treatment. During remission, the L/R ratio was 0.035 +/- 0.028; this did not differ significantly from the value obtained after treatment. We conclude that intestinal permeability is useful for investigating disease activity in patients with Crohn's disease.